Rating History
Dissemination Date Long-Term Rating Short-Term Rating Outlook Action Rating Watch
18-May-26 A A1 Positive Maintain -
13-Jun-25 A A1 Stable Maintain -
13-Jun-24 A A1 Stable Maintain -
13-Jun-23 A A1 Stable Maintain -
14-Jun-22 A A1 Stable Maintain -
About the Entity

Ghani Chemical Industries Limited is a listed entity, incorporated in 2015. The Company is a subsidiary (~49.07%) of Ghani Global Holdings Limited which is owned majorly by the Ghani Family (~51.89%). The remaining shareholding lies in Ghani ChemWorld Ltd. ~12.27%, directors of the Company and the general public. Mr. Masroor Ahmad Khan is the Chairman of the board while Mr. Hafiz Farooq Ahmad holds the office of CEO. They are assisted by a management team with extensive experience and a diversified skillset.

Rating Rationale

Ghani Chemical Industries Limited (GCIL or "the Company") is engaged in the manufacturing, sale, and trading of industrial and medical gases, including liquid and compressed oxygen, nitrogen, and argon. The Company serves a diversified client base spanning healthcare, oil and gas, steel, chemicals, pharmaceuticals, food and beverages, and general manufacturing. GCIL operates four air separation units (ASUs) across Lahore and Port Qasim, Karachi, with an aggregate installed capacity of approximately 710 tons per day (TPD), complemented by the recently operationalized 275 TPD facility at Hattar Special Economic Zone. The Hattar plant, among the most modern ASUs in the country, has meaningfully enhanced operational scale, energy efficiency, and cost absorption across the production base. Following the completion of the Calcium Carbide segment demerger into a separately listed entity, the Company's revenue base is now fully concentrated in the core gases, distributed between the industrial segment (~65%) and the medical segment (~35%). As per management’s representation, GCIL commands an estimated market share of 40%, consolidating its position as the leading domestic producer. Pakistan's industrial and medical gases sector continues to demonstrate structural resilience. Demand for medical gases is supported by expanding hospital networks, growing healthcare infrastructure investment, rising surgical volumes, and increasing adoption of piped medical gas systems across institutional healthcare facilities. The industrial segment remains closely linked to large-scale manufacturing (LSM) activity, encompassing steel processing, automobile production, engineering and fabrication, and CPEC-related industrial projects. Moderating policy rates, easing inflationary pressures, and a more stable exchange rate environment are expected to provide incremental support to industrial demand going forward. Sector performance overall remains positively correlated with the trajectory of healthcare investment and the pace of LSM recovery. During 9MFY26, the Company recorded a net revenue of PKR 6.0 billion, reflecting a sizeable growth driven by disciplined pricing and stronger demand realization across both product segments. Furthermore, the margin materially strengthened at all levels. These improvements reflect the combined effect of an optimized pricing strategy, operating leverage from expanded capacity, and energy efficiencies embedded in the Hattar facility. The Positive Outlook reflects the consistent topline growth trajectory, material margin improvement, and strengthening competitive positioning. Diversification into LNG and CO₂ production through the joint venture with Mari Energies Limited, the exclusive agreement with Precision UK for medical gas pipeline systems, and the planned LPG storage facility at Phool Nagar further broaden the Company's revenue and growth horizon. GCIL operates under the oversight of a strategic governing board and an experienced management team. The financial risk profile is characterized by comfortable coverage metrics, adequate liquidity, and a manageable working capital cycle. The capital structure is moderately leveraged, with long-term facilities supporting capacity investment and short-term borrowings addressing working capital requirements.

Key Rating Drivers

The ratings are dependent upon the Company's ability to sustain topline growth, with stability in margins, effectively utilize enhanced capacities, and maintain disciplined management of financial risk, particularly leverage and debt coverage ratios. Successful execution of diversification initiatives and consistent growth in market share would be supportive of a positive rating action.

Profile
Legal Structure

Ghani Chemical Industries Limited ( Hereinafter referred to as "GCIL" or "the Company" was incorporated on November 23, 2015, as a Private Limited Company under the Companies Ordinance, 1984 (since repealed and replaced by the Companies Act, 2017). The Company was subsequently converted into a Public Limited Company on April 20, 2017, and its shares were listed on the Pakistan Stock Exchange on November 14, 2022. The registered office of the Company is located at 10‑N, Model Town Extension, Lahore. The Company operates manufacturing facilities at Phool Nagar, District Kasur, and within the Industrial Zone at Port Qasim, Karachi.


Background

In July 2019, pursuant to a Scheme of Compromises, Arrangements, and Reconstruction approved within the Ghani Global Group, the manufacturing operations of Ghani Gases Limited, together with all related assets and liabilities, were transferred to Ghani Chemical Industries Limited. Following this restructuring, the Company operates as a subsidiary of Ghani Global Holdings Limited, formerly known as Ghani Gases Limited.


Operations

Ghani Chemical Industries Limited is engaged in the manufacturing, sale, and trading of medical and industrial gases, along with related chemicals. Its product portfolio encompasses liquid nitrogen, liquid oxygen, liquid argon, compressed medical oxygen, compressed nitrogen, compressed argon, and other high‑purity gases. These products are supplied to a diverse customer base across multiple end‑use sectors, including healthcare, oil and gas, chemicals and fertilizers, ship breaking and scrap cutting, pharmaceuticals, glass manufacturing, food and beverages, steel and iron mills, pulp and paper, as well as other industrial and commercial applications. The Company operates modern production facilities with an aggregate installed capacity of approximately ~710 tons per day (TPD). This scale enables GCIL to meet large‑volume demand while ensuring operational efficiency, consistent quality standards, and reliable supply across its served markets.

1) Oxygen is widely used in medical and chemical processing, general engineering, fabrication, steel manufacturing, welding, ship breaking, oxidation processes, and pulp and paper industries.

2) Nitrogen finds application in chemical processes, oil and gas exploration, blanketing, healthcare, and food freezing and storage. 

3) Argon is utilized in healthcare, deep‑sea environments, welding, food and beverage industries, cinematography, and lighting.

Through its diversified product range and strong operational base, GCIL plays a vital role in supporting Pakistan’s healthcare sector and industrial growth, while maintaining a focus on efficiency, reliability, and quality.


Ownership
Ownership Structure

Company’s majority shareholding is held by its parent Company, Ghani Global Holdings Limited, which is primarily owned by the Ghani Family and holds ~49.07% of the Company’s issued share capital. The remaining shares are held by Ghani ChemWorld Limited (~12.27%), along with the Company’s directors and the general public.


Stability

The restructuring undertaken by the Ghani Group in 2020 marked a strategic realignment of the Company’s operational and governance framework. As part of this transformation, Ghani Gases Limited discontinued its role as a manufacturing entity and was repositioned as the Group’s holding Company, subsequently being renamed Ghani Global Holdings Limited. Following the restructuring, manufacturing operations were consolidated under dedicated operating subsidiaries, while the holding Company transitioned to a supervisory, strategic, and investment‑focused role. This reorganization reflects the Group’s long‑term vision to streamline operations, enhance corporate governance and oversight, and support future growth, expansion, and diversification through centralized management of its subsidiaries and investments.


Business Acumen

The sponsors of GCIL bring an established legacy of entrepreneurial leadership, underpinned by more than five decades of diversified business experience across multiple industrial and commercial sectors. Their portfolio spans industries including industrial gases, engineering, mining, glass manufacturing, real estate, automobiles, and food, demonstrating a sustained ability to build, scale, and manage businesses across varied economic cycles. This extensive cross‑sector exposure has enabled the sponsors to develop strong capabilities in strategic planning, operational execution, and long‑term value creation. Their consistent focus on innovation, prudent expansion, and market adaptability reflects a deep understanding of industry dynamics and risk management. Collectively, this breadth of experience strengthens corporate governance, supports informed decision‑making, and provides a solid foundation for sustainable growth and resilience across the Group’s operations.


Financial Strength

As of May 31, 2026, the Ghani Group—comprising Ghani Global Holdings Limited, Ghani Global Glass Limited, Ghani Chemical Industries Limited, and the recently incorporated Ghani ChemWorld Limited—reported consolidated equity of PKR 21.2 billion. This capital base reflects the Group’s established financial strength, diversified business presence, and prudent balance‑sheet management across its operating entities. The scale of equity provides a solid buffer against cyclicality and supports ongoing investments, capacity expansion, and strategic initiatives across the Group’s portfolio. Furthermore, the Group has demonstrated both the financial capacity and the strategic inclination to support GCIL, through its centralized holding‑Company structure and historical capital allocations. This ongoing support framework enhances financial flexibility, reinforces creditor comfort, and contributes to the Company’s operational stability and long‑term sustainability.


Governance
Board Structure

The Company is overseen by a seven‑member Board of Directors, chaired by Mr. Masroor Ahmad Khan. The Board comprises six representatives from the sponsoring family, including the Chief Executive Officer, ensuring continuity in leadership, alignment with the Group’s strategic vision, and effective oversight of operations. In addition, one director represents the Group’s employees, contributing operational insight and reinforcing internal alignment across management levels. To strengthen corporate governance and promote independent judgment, the Board includes two independent directors, and Mr. Hafiz Imran Latif. Their inclusion provides external perspectives, enhances checks and balances, and supports objective evaluation of strategic and operational matters. Overall, the Board’s composition reflects a balance between sponsor representation, independence, and sectoral experience, enabling the Company to maintain governance stability while supporting prudent decision‑making, transparency, and sustainable long‑term growth.


Members’ Profile

Mr. Masroor Ahmad Khan, Chairman of the Board, has been actively associated with the family’s business since 1985 and has played a central role in shaping its strategic direction over several decades. His extensive leadership experience and industry knowledge have contributed to the Company’s consistent growth and organizational development. Mr. Hafiz Farooq Ahmad is the Chief Executive Officer of GCIL, leading the Company with a visionary approach. With an exceptional academic background, he holds a Bachelor's degree in Engineering, reflecting his technical expertise. His career highlights include strategic growth initiatives and operational excellence within the group’s diversified portfolio.The majority of the Company’s directors have served on the Board since its inception, bringing with them diverse experience drawn from multiple industries. This continuity in Board composition supports institutional knowledge, informed decision‑making, and a comprehensive understanding of the Company’s operational and strategic priorities. Collectively, the Board’s long-standing tenure and experience provide stability and continuity, positioning GCIL to remain resilient, responsive to change, and well‑placed to pursue sustainable long‑term growth.


Board Effectiveness

GCIL convenes its Board of Directors’ meetings on a quarterly basis, in compliance with the corporate governance requirements applicable to publicly listed companies. These meetings serve as a key forum for providing strategic oversight, reviewing operational and financial performance, and guiding long‑term strategic planning in line with the Company’s objectives. In order to ensure transparency, accountability, and regulatory compliance, detailed minutes of each meeting are properly recorded and maintained. This structured governance process supports effective decision‑making, reinforces internal controls, and fosters stakeholder confidence by ensuring alignment with the Company’s strategic vision and recognized best practices.


Financial Transparency

M/s ShineWing Hameed Chaudhri & Co., Chartered Accountants, has been appointed as the external auditor of GCIL. The firm is QCR‑rated and is included on the State Bank of Pakistan’s panel of approved auditors, reflecting compliance with applicable professional and regulatory standards. The auditors have issued an unqualified audit opinion on the Company’s financial statements for the financial year ended FY25, indicating that the financial statements present a true and fair view in accordance with the applicable financial reporting framework.


Management
Organizational Structure

The Company operates through a well-structured framework comprising six key functional divisions, each led by a dedicated divisional head who reports directly to the Chief Executive Officer. This strategic organizational model fosters operational efficiency, enhances communication, and ensures cohesive alignment with the Company’s broader vision and objectives. By overseeing their respective domains, the divisional heads play a vital role in driving performance optimization, implementing innovative initiatives, and steering their departments toward sustainable growth. Their leadership contributes to a dynamic, well-coordinated operational environment, enabling the Company to navigate industry challenges while maintaining a competitive edge. This structured approach not only streamlines management but also reinforces accountability, collaboration, and strategic execution across all levels of the organization.


Management Team

Mr. Hafiz Farooq Ahmad serves as the Chief Executive Officer of GCIL, steering the Company with visionary leadership and a commitment to excellence. Under his guidance, the management team consists of highly skilled and experienced professionals, each bringing deep expertise not only in the industrial gases sector but also across various other industries. This dynamic and diverse leadership team plays a crucial role in shaping the Company's strategic direction, optimizing operational efficiency, and driving sustainable growth. Their collective knowledge and strategic insights enable the Company to navigate industry challenges effectively, seize emerging opportunities, and maintain its competitive edge in an evolving market landscape. Through innovation, collaboration, and a results-driven approach, the leadership continues to strengthen the Company’s foundation for long-term success.


Effectiveness

GCIL upholds a strong and secure IT infrastructure, equipped with comprehensive controls to ensure seamless system operations and data security. The Company prioritizes technological integrity, implementing advanced measures to safeguard critical information and optimize efficiency across its digital platforms. To maintain informed leadership and promote strategic decision-making, regular reports are presented to senior management, providing insights that drive data-driven business strategies. Additionally, specialized management committees are established to oversee key operational challenges, ensuring that relevant issues are addressed proactively. The meticulous documentation of meeting minutes reinforces transparency, accountability, and regulatory compliance, strengthening the organization's governance framework. This structured approach enables the Company to remain agile, resilient, and well-positioned for future advancements in the digital landscape.


MIS

The Company has implemented an advanced Oracle ERP solution, significantly enhancing the quality and efficiency of its reporting system. This integration has streamlined operations, improved data accuracy, and provided management with real-time insights for better decision-making and strategic planning. Additionally, the ERP system supports seamless communication and collaboration across various departments, contributing to the overall effectiveness of the Company's business processes.


Control Environment

Management Information System (MIS) reports play a vital role in GCIL's operational oversight, covering critical areas such as inventory management, finance, production, sales, and overall business operations. These reports are regularly presented to senior management, ensuring data-driven decision-making that enhances efficiency and strategic direction. To further strengthen its technological capabilities, the Company has integrated Oracle technology into its database system. This integration ensures the timely availability and accessibility of essential business information, facilitating seamless workflows and informed leadership decisions. By leveraging advanced data management tools, GCIL optimizes operational effectiveness, improves financial planning, and enhances long-term business sustainability. This robust digital infrastructure reinforces the Company's commitment to innovation, efficiency, and strategic excellence.


Business Risk
Industry Dynamics

Pakistan’s industrial gases sector continues to demonstrate steady growth, driven by rising demand from key end‑user industries such as healthcare, manufacturing, metallurgy, and infrastructure development. However, the sector’s close linkage with Large‑Scale Manufacturing (LSM) meant that the slowdown in LSM during FY25 (contracting by ~0.73%) translated into softer revenue growth. Sector revenues decelerated from ~27.4% in FY24 to ~14.6% in FY25, reaching PKR ~25,961 million (FY24: PKR ~22,655 million). The country’s total installed production capacity for industrial gases stood at approximately 1,300 tons per day (TPD) in FY25, with demand primarily emanating from LSM and healthcare. Notably, two leading players dominated the market, contributing nearly ~90% of sector revenues. Their combined revenue rose ~19.5% year‑on‑year to PKR ~23.3 billion. While overall LSM contracted, certain industries—including automobiles, food and beverages, pharmaceuticals, and construction—registered strong growth, sustaining demand for industrial gases. Core gases such as oxygen, nitrogen, and carbon dioxide remain indispensable inputs across steel production, food processing, energy applications, and medical treatments. The healthcare sector, particularly hospitals and pharmaceutical manufacturers, continues to be a major consumer, underpinned by persistent demand for oxygen and nitrogen. Simultaneously, ongoing industrial expansion, infrastructure projects, and energy‑related developments are fueling demand for specialized gases. Industry dynamics are increasingly shaped by sustainability and operational efficiency. Companies are investing in advanced production, separation, and distribution technologies to enhance efficiency and minimize environmental impact. Pricing trends are influenced by energy costs, fluctuations in oil and natural gas prices, gas purity and quality, and the degree of product customization required by end‑users. Capacity remains concentrated among a few large players. Pakistan Oxygen Limited, the market leader, has an installed capacity of ~533 TPD, with ~430 TPD currently operational. The Pak Oxygen Limited has announced expansion initiatives to strengthen supply reliability and meet future demand. Ghani Chemical Industries Limited follows with ~710 TPD of installed capacity. The sector’s concentrated structure, high capital intensity, and technical requirements create moderate entry barriers, contributing to relatively stable competitive dynamics.


Relative Position

The sector is organized and concentrated within two major players, i.e., Pakistan Oxygen Limited and Ghani Chemicals Indutries Limited. Other companies include Multan Gases, Sharif Gases, Agha Gas, Sultan Oxygen, and MediGas. GCIL is among the leading participants in Pakistan’s industrial gases sector, ranking as the second‑largest producer with a substantial market presence. The sector is currently led by Pakistan Oxygen Limited, which holds an estimated market share of ~40% and benefits from a comparatively broader operational footprint. GCIL follows closely with an estimated market share of around ~34%, supported by its established production base, diversified product portfolio, and strong positioning across key demand centers. While Pakistan Oxygen maintains leadership in terms of scale, GCIL has demonstrated consistent capacity expansion and operational execution, which has strengthened its competitive standing over time. The Company’s ongoing investments in large‑scale air separation facilities are expected to further enhance its supply capabilities and market relevance. Overall, GCIL maintains a solid competitive position in a market characterized by high entry barriers, stable demand from core industries, and a limited number of large‑scale producers.


Revenues

The Company’s revenue is primarily driven by its industrial gases segment, with Liquid Oxygen and Liquid Nitrogen being the key contributors. During 9MFY26, the Company recorded net sales of PKR 5,987mln, demonstrating growth compared to the corresponding period last year (FY25: PKR 7,435mln). This performance was supported by steady demand from core end‑user sectors, including healthcare, manufacturing, and energy, where consumption of industrial gases remained resilient. Revenue growth was further supported by enhanced operational efficiency, driven by improved capacity utilization and production optimization initiatives. These measures enabled the Company to meet customer requirements effectively and maintain reliable supply. Overall, the combination of sustained demand and operational improvements contributed to stable revenue performance and strengthened the Company’s competitive position within the industrial gases market.


Margins

The Company reported an improvement in profitability metrics during 9MFY26, with gross margins increasing to ~54%, compared to around ~46% in FY25. This improvement reflects more favorable pricing dynamics and improved cost absorption. Net margins also strengthened, reaching ~32% in 9MFY26 versus about ~27% in FY25, mainly supported by controlled operating costs and enhanced operational efficiencies. Overall, the improvement in margins indicates better earnings quality, while maintaining competitiveness within the operating environment.


Sustainability

The Company has entered into a Joint Venture Agreement with Mari Energies Limited and, in January 2026, made an initial equity investment of PKR 98mln, representing its ~49% share, in GHG Emission Mitigation Limited—a newly incorporated project Company. The project is designed to capture and process cold-vent and exhaust gases from the Sachal Gas Processing Complex. This initiative represents a first-of-its-kind undertaking in Pakistan, with planned production capacities of 80,000 tons per annum of liquefied natural gas (LNG) and 55,000 tons per annum of industrial- and food-grade carbon dioxide (CO₂). The total project cost is estimated at PKR 14bn. Upon commercialization, the project is expected to generate annual revenues of approximately PKR ~17bn, with profitability anticipated to strengthen over the medium to long term, subject to successful execution and prevailing market conditions. The Company has entered into an exclusive agreement with Precision UK, a well‑established United Kingdom–based entity with operations in over 100 countries and a significant presence covering approximately 90% of the UK market. Precision UK is engaged in the manufacture and marketing of medical gas pipeline systems and equipment under the CPX brand. Under this collaboration, Precision UK and the Company will jointly market and install Medical Gas Pipeline (MGP) systems and equipment within Pakistan’s healthcare sector. The agreement was formally executed at a ceremony in Lahore, attended by representatives from both public and private hospitals across the country. The medical gas pipeline systems and equipment segment is receiving increased strategic focus, supported by the rollout of multiple healthcare projects nationwide and a growing pipeline of new developments. This partnership is expected to contribute to revenue growth over the medium term, while complementing the Company’s existing medical and industrial gases portfolio. In addition to the above, the Company has initiated diversification into adjacent business areas through the establishment of a 450‑metric‑ton capacity LPG storage and filling plant at Phool Nagar, District Kasur. The project will be executed through a wholly owned subsidiary of GCIL to support operations across the country. The required license for the project has been obtained from the Oil and Gas Regulatory Authority (OGRA), Islamabad. Following the completion of requisite regulatory and procedural formalities, construction of the facility is expected to commence in due course. This initiative reflects the Company’s focus on expanding its operational footprint and strengthening long‑term growth prospects through business diversification. The Company is also proactively pursuing several new contracts, which are currently in the negotiation and development stages. These agreements are expected to play a crucial role in strengthening financial stability by ensuring steady revenue streams and enhanced profitability. Additionally, securing long-term partnerships will help mitigate risks associated with fluctuating demand and provide a solid foundation for sustained growth. While short-term financial gains may take time, these strategic efforts demonstrate a forward-looking approach, ensuring the Company is well-positioned for future expansion and operational efficiency.


Financial Risk
Working capital

In 9MFY26, the Company’s inventory days improved to ~4 days from around ~6 days in FY25, reflecting efficient inventory management and a streamlined operating cycle. However, trade receivable days increased to about ~125 days compared to ~104 days in FY25, largely attributable to extended credit terms and slower collections from certain customers. Consequently, gross working capital days rose to around ~129 days from ~110 days in FY25. Trade payable days increased to ~22 days in 9MFY26 from about ~9 days in FY25, indicating relatively longer settlement periods with suppliers, potentially as part of routine cash flow management. Overall, net working capital days stood at ~106 days in 9MFY26, compared to around ~101 days in FY25. While the working capital position remains manageable, the increase in receivable days underscores the importance of maintaining effective collection mechanisms to support liquidity and sustain cash flow efficiency.


Coverages

In 9MFY26, the Company reported free cash flows from operations (FCFO) of PKR 2,655 million, compared to PKR 1,835 million in FY25. This improvement reflects stronger operating performance and better cash generation from core activities. The interest coverage ratio also strengthened, rising to ~6.2x in 9MFY26 from ~4.3x in FY25, indicating that the Company’s earnings before interest and taxes (EBIT) are now more comfortably covering its interest obligations. This is a positive signal of enhanced profitability and reduced short‑term financial risk. On the other hand, the debt coverage ratio weakened to ~0.7x in 9MFY26 from ~1.3x in FY25. This suggests that despite higher operating cash flows, the Company is facing relatively greater pressure in meeting debt servicing requirements, likely due to increased financing costs and restructuring initiatives. Overall, these indicators highlight the short‑term financial impact of strategic restructuring and higher borrowing costs. While such measures may support long‑term growth and capacity expansion, disciplined cash flow management will remain essential. Strengthening liquidity buffers and improving debt servicing capacity will be critical to ensure financial stability and sustain growth momentum.


Capitalization

In 9MFY26, Company's leverage ratio remained largely unchanged at ~34%, compared to around ~33.9% in FY25, indicating stability in the Company’s overall capital structure. However, a change was observed in the composition of borrowings, as short-term financing accounted for about ~60% of total borrowings in 9MFY26, compared to ~62% in FY25. This adjustment suggests a recalibration of the debt mix, potentially reflecting management’s approach to aligning financing sources with operational cash flow requirements and prevailing market conditions. While short-term borrowings may support flexibility and working capital management, they also require effective liquidity planning to mitigate refinancing and interest rate exposure. Overall, the shift appears to reflect routine balance sheet management rather than a material change in financial risk profile.


 
 

May-26

www.pacra.com


(PKR mln)


Mar-26
9M
Jun-25
12M
Jun-24
12M
Jun-23
12M
A. BALANCE SHEET
1. Non-Current Assets 10,302 10,039 11,185 7,778
2. Investments 0 0 0 0
3. Related Party Exposure 3,252 1,578 1,242 1,777
4. Current Assets 5,809 4,625 4,454 3,573
a. Inventories 79 95 161 79
b. Trade Receivables 3,385 2,082 2,142 1,021
5. Total Assets 19,364 16,243 16,881 13,128
6. Current Liabilities 1,633 1,291 1,610 775
a. Trade Payables 675 308 60 253
7. Borrowings 5,429 4,657 4,514 2,811
8. Related Party Exposure 81 40 0 0
9. Non-Current Liabilities 1,521 1,096 903 712
10. Net Assets 10,700 9,158 9,854 8,830
11. Shareholders' Equity 10,700 9,158 9,854 8,830
B. INCOME STATEMENT
1. Sales 5,987 7,435 5,437 4,332
a. Cost of Good Sold (2,736) (4,023) (3,825) (2,872)
2. Gross Profit 3,252 3,412 1,613 1,460
a. Operating Expenses (694) (493) (387) (409)
3. Operating Profit 2,558 2,919 1,226 1,051
a. Non Operating Income or (Expense) 71 169 448 255
4. Profit or (Loss) before Interest and Tax 2,628 3,088 1,674 1,306
a. Total Finance Cost (426) (453) (389) (374)
b. Taxation (289) (623) (499) (424)
6. Net Income Or (Loss) 1,914 2,012 786 508
C. CASH FLOW STATEMENT
a. Free Cash Flows from Operations (FCFO) 2,655 1,835 1,573 1,226
b. Net Cash from Operating Activities before Working Capital Changes 2,251 1,195 1,573 1,226
c. Changes in Working Capital (2,782) (284) 143 (1,190)
1. Net Cash provided by Operating Activities (531) 912 1,715 37
2. Net Cash (Used in) or Available From Investing Activities (504) (1,340) (3,307) (412)
3. Net Cash (Used in) or Available From Financing Activities 785 690 1,535 46
4. Net Cash generated or (Used) during the period (250) 261 (56) (330)
D. RATIO ANALYSIS
1. Performance
a. Sales Growth (for the period) 7.4% 36.7% 25.5% 2.8%
b. Gross Profit Margin 54.3% 45.9% 29.7% 33.7%
c. Net Profit Margin 32.0% 27.1% 14.5% 11.7%
d. Cash Conversion Efficiency (FCFO adjusted for Working Capital/Sales) -2.1% 20.9% 31.5% 0.8%
e. Return on Equity [ Net Profit Margin * Asset Turnover * (Total Assets/Shareholders' Equity )] 25.7% 21.2% 8.4% 6.2%
2. Working Capital Management
a. Gross Working Capital (Average Days) 129 110 114 87
b. Net Working Capital (Average Days) 106 101 104 70
c. Current Ratio (Current Assets / Current Liabilities) 3.6 3.6 2.8 4.6
3. Coverages
a. EBITDA / Finance Cost 6.6 5.6 4.8 4.0
b. FCFO / Finance Cost+CMLTB+Excess STB 2.9 1.9 1.8 1.6
c. Debt Payback (Total Borrowings+Excess STB) / (FCFO-Finance Cost) 0.7 1.3 2.4 2.0
4. Capital Structure
a. Total Borrowings / (Total Borrowings+Shareholders' Equity) 33.7% 33.9% 31.4% 24.1%
b. Interest or Markup Payable (Days) 109.3 125.8 326.8 122.9
c. Entity Average Borrowing Rate 11.4% 8.8% 10.0% 12.7%

May-26

www.pacra.com

May-26

www.pacra.com

  1. Rating Team Statements
    1. Rating is just an opinion about the creditworthiness of the entity and does not constitute a recommendation to buy, hold, or sell any security of the entity rated or to buy, hold, or sell the security rated, as the case may be. (Chapter III; 14-3-(x))
    2. Conflict of Interest
      1. The Rating Team or any of their family members have no interest in this rating (Chapter III; 12-2-(j))
      2. PACRA, the analysts involved in the rating process, and members of its rating committee and their family members do not have any conflict of interest relating to the rating done by them (Chapter III; 12-2-(e) & (k))
      3. The analyst is not a substantial shareholder of the customer being rated by PACRA [Annexure F; d-(ii)]
      4. Explanation: for the purpose of the above clause, the term "family members" shall include only those family members who are dependent on the analyst and members of the rating committee.
  2. Restrictions
    1. No director, officer, or employee of PACRA communicates the information acquired by him for use for rating purposes to any other person, except where required under law to do so. (Chapter III; 10-(5))
    2. PACRA does not disclose or discuss with outside parties or make improper use of the non-public information which has come to its knowledge during a business relationship with the customer. (Chapter III; 10-7-(d))
    3. PACRA does not make proposals or recommendations regarding the activities of rated entities that could impact a credit rating of the entity subject to rating. (Chapter III; 10-7-(k))
  3. Conduct of Business
    1. PACRA fulfills its obligations in a fair, efficient, transparent, and ethical manner and renders high standards of services in performing its functions and obligations. (Chapter III; 11-A-(a))
    2. PACRA uses due care in the preparation of this Rating Report. Our information has been obtained from sources we consider to be reliable, but its accuracy or completeness is not guaranteed. PACRA does not, in every instance, independently verify or validate information received in the rating process or in preparing this Rating Report. (Clause 11-(A)(p))
    3. PACRA prohibits its employees and analysts from soliciting money, gifts, or favors from anyone with whom PACRA conducts business. (Chapter III; 11-A-(q))
    4. PACRA ensures before the commencement of the rating process that an analyst or employee has not had a recent employment or other significant business or personal relationship with the rated entity that may cause or may be perceived as causing a conflict of interest. (Chapter III; 11-A-(r))
    5. PACRA maintains the principle of integrity in seeking rating business. (Chapter III; 11-A-(u))
    6. PACRA promptly investigates in the event of misconduct or a breach of the policies, procedures, and controls, and takes appropriate steps to rectify any weaknesses to prevent any recurrence, along with suitable punitive action against the responsible employee(s). (Chapter III; 11-B-(m))
  4. Independence & Conflict of Interest
    1. PACRA receives compensation from the entity being rated or any third party for the rating services it offers. The receipt of this compensation has no influence on PACRA’s opinions or other analytical processes. In all instances, PACRA is committed to preserving the objectivity, integrity, and independence of its ratings. Our relationship is governed by two distinct mandates: i) rating mandate - signed with the entity being rated or issuer of the debt instrument, and ii) fee mandate - signed with the payer, which can be different from the entity.
    2. PACRA does not provide consultancy/advisory services or other services to any of its customers or their associated companies and associated undertakings that are being rated or have been rated by it during the preceding three years, unless it has an adequate mechanism in place ensuring that the provision of such services does not lead to a conflict of interest situation with its rating activities. (Chapter III; 12-2-(d))
    3. PACRA discloses that no shareholder directly or indirectly holding 10% or more of the share capital of PACRA also holds directly or indirectly 10% or more of the share capital of the entity which is subject to rating or the entity which issued the instrument subject to rating by PACRA. (Chapter III; 12-2-(f))
    4. PACRA ensures that the rating assigned to an entity or instrument is not affected by the existence of a business relationship between PACRA and the entity or any other party, or the non-existence of such a relationship. (Chapter III; 12-2-(i))
    5. PACRA ensures that the analysts or any of their family members shall not buy, sell, or engage in any transaction in any security which falls in the analyst’s area of primary analytical responsibility. This clause, however, does not apply to investments in securities through collective investment schemes. (Chapter III; 12-2-(l))
    6. PACRA has established policies and procedures governing investments and trading in securities by its employees and for monitoring the same to prevent insider trading, market manipulation, or any other market abuse. (Chapter III; 11-B-(g))
  5. Monitoring and Review
    1. PACRA monitors all the outstanding ratings continuously, and any potential change therein due to any event associated with the issuer, the security arrangement, the industry, etc., is disseminated to the market immediately and in an effective manner after appropriate consultation with the entity/issuer. (Chapter III; 17-(a))
    2. PACRA reviews all the outstanding ratings periodically on an annual basis. Provided that public dissemination of annual review and in an instance of change in rating will be made. (Chapter III; 17-(b))
    3. PACRA initiates an immediate review of the outstanding rating upon becoming aware of any information that may reasonably be expected to result in downgrading of the rating. (Chapter III; 17-(c))
    4. PACRA engages with the issuer and the debt securities trustee to remain updated on all information pertaining to the rating of the entity/instrument. (Chapter III; 17-(d))
  6. Probability of Default
    1. PACRA’s Rating Scale reflects the expectation of credit risk. The highest rating has the lowest relative likelihood of default (i.e., probability). PACRA’s transition studies capture the historical performance behavior of a specific rating notch. Transition behavior of the assigned rating can be obtained from PACRA’s Transition Study available at our website. (www.pacra.com) However, the actual transition of rating may not follow the pattern observed in the past. (Chapter III; 14-3(f)(vii))
  7. Proprietary Information
    1. All information contained herein is considered proprietary by PACRA. Hence, none of the information in this document can be copied or otherwise reproduced, stored, or disseminated in whole or in part in any form or by any means whatsoever by any person without PACRA’s prior written consent.

May-26

www.pacra.com